Status: Recruiting
A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients
This study includes two parts, part 1 is SSGJ-706 monotherapy therapy for advanced NSCLC and part 2 is SSGJ-706 combination therapy for advanced NSCLC
Participants needed: 240
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shenyang Sunshine Pharmaceutical Co., LTD.Updated: Dec 18, 2025Locations: 1
Eligibility criteria
Males and/or females over age 18 [+4]
Known uncontrolled or symptomatic central nervous system metastatic disease. [+4]